Nemaura Medical (NMRD) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSustainabilityTrends NMRD vs. GMVDF, VRAYQ, AHPI, MOTS, BRSH, DRTSW, ANZUW, BBLGW, BRSHW, and GMVDWShould you be buying Nemaura Medical stock or one of its competitors? The main competitors of Nemaura Medical include G Medical Innovations (GMVDF), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Motus GI (MOTS), Bruush Oral Care (BRSH), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and G Medical Innovations (GMVDW). These companies are all part of the "medical equipment" industry. Nemaura Medical vs. G Medical Innovations ViewRay Allied Healthcare Products Motus GI Bruush Oral Care Alpha Tau Medical Anzu Special Acquisition Corp I Bone Biologics Bruush Oral Care G Medical Innovations Nemaura Medical (NASDAQ:NMRD) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability, dividends and community ranking. Which has higher valuation and earnings, NMRD or GMVDF? Nemaura Medical has higher earnings, but lower revenue than G Medical Innovations. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNemaura Medical$80K0.00-$14.14M-$0.39N/AG Medical Innovations$4.42M0.00-$24.63MN/AN/A Is NMRD or GMVDF more profitable? Company Net Margins Return on Equity Return on Assets Nemaura MedicalN/A N/A N/A G Medical Innovations N/A N/A N/A Do institutionals and insiders hold more shares of NMRD or GMVDF? 4.4% of Nemaura Medical shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by company insiders. Comparatively, 37.1% of G Medical Innovations shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more volatility and risk, NMRD or GMVDF? Nemaura Medical has a beta of 0.09, indicating that its share price is 91% less volatile than the S&P 500. Comparatively, G Medical Innovations has a beta of 2.69, indicating that its share price is 169% more volatile than the S&P 500. Does the media refer more to NMRD or GMVDF? In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score. Company Overall Sentiment Nemaura Medical Neutral G Medical Innovations Neutral Does the MarketBeat Community favor NMRD or GMVDF? Nemaura Medical received 4 more outperform votes than G Medical Innovations when rated by MarketBeat users. CompanyUnderperformOutperformNemaura MedicalOutperform Votes457.14% Underperform Votes342.86% G Medical InnovationsN/AN/A SummaryNemaura Medical and G Medical Innovations tied by winning 3 of the 6 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Nemaura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMRD vs. The Competition Export to ExcelMetricNemaura MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$10,000.00$4.48B$5.10B$8.84BDividend YieldN/A36.79%5.04%4.07%P/E RatioN/A14.3295.1214.22Price / SalesN/A44.111,217.3088.42Price / CashN/A52.2739.4936.27Price / BookN/A5.836.976.37Net Income-$14.14M$13.76M$118.73M$225.56M Nemaura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMRDNemaura MedicalN/AN/AN/AN/A$10,000.00$80,000.000.0040GMVDFG Medical InnovationsN/AN/AN/AN/A$30,000.00$4.42M0.0072VRAYQViewRayN/AN/AN/AN/A$20,000.00$102.21M0.00300AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150MOTSMotus GIN/A$0.00flatN/A-100.0%$5,000.00$320,000.000.0030BRSHBruush Oral CareN/A$0.00flatN/A-99.7%$1,000.00$2.92M0.0011DRTSWAlpha Tau MedicalN/A$0.22+29.8%N/A-15.4%$0.00N/A0.0080News CoverageGap UpANZUWAnzu Special Acquisition Corp IN/A$0.06flatN/AN/A$0.00N/A0.002BBLGWBone BiologicsN/A$28.49flatN/AN/A$0.00N/A0.002BRSHWBruush Oral CareN/A$0.01flatN/AN/A$0.00$2.92M0.0011GMVDWG Medical InnovationsN/A$0.02flatN/AN/A$0.00$4.42M0.0072 Related Companies and Tools Related Companies GMVDF Competitors VRAYQ Competitors AHPI Competitors MOTS Competitors BRSH Competitors DRTSW Competitors ANZUW Competitors BBLGW Competitors BRSHW Competitors GMVDW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NMRD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMRD Stock Alerts